DeutschNewstral
Article
Mmarketwatch.com on 2023-03-08 23:58
Lilly's drug aimed at preventing Alzheimer's fails1 min read
Related news
- BThe FDA Rejected Lilly's Alzheimer's Drug. Why It's Only a Setback,3 min readbarrons.com
- MWhy the FDA didn't grant an approval to Lilly's Alzheimer's drug3 min readmarketwatch.com
Preventing Alzheimer'sBBC- MThe latest Alzheimer's risk? Coffee3 min readmarketwatch.com
- BEli Lilly's Earnings Top Forecasts and 2022 Outlook Is Maintained1 min readbarrons.com
- BEli Lilly's Insulin Price Cap Squeezes Other Drug Makers4 min readbarrons.com
- BFDA's Call on Lilly's Covid Drug Is Lifting a Partner's Beaten-Down Stock3 min readbarrons.com
- BAfter Lilly's Selloff, Citi Declares the Stock a Buy2 min readbarrons.com
- BBiogen's Aduhelm Struggles Don't Hurt Lilly's Outlook, Says Analyst3 min readbarrons.com
- MLilly's experimental weight-loss drug may be a 'multibillion-dollar opportunity'4 min readmarketwatch.com
- BThe Most Exciting Market for Lilly's Diabetes Drug May Be Something Else3 min readbarrons.com
- MLilly's ambitious new drug Mounjaro fails to impress in the fourth quarter3 min readmarketwatch.com
- BWhy Eli Lilly's Insulin Price Cuts Could Boost the Stock4 min readbarrons.com
Lilly's Alzheimer's Drug Fails, and Morewsj.com- MLilly's stock falls on failed Alzheimer's studymarketwatch.com
- BPreventing Client Complaints Before They Happen5 min readbarrons.com
- BPreventing the Rising Threat of Financial Fraud5 min readbarrons.com
- BMedicare Will Limit Coverage of Biogen's Alzheimer's Drug2 min readbarrons.com